Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome

Chest

Volumn 121, Issue 2, 2002, Pages 656-659

  Preston, Ioana R ^a   Klinger, James R ^a   Houtchens, Jeanne ^a   Nelson, David ^a   Mehta, Sangeeta ^a   Hill, Nicholas S ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

CREST; Epoprostenol; Nitric oxide; Pulmonary edema; Pulmonary hypertension; Scleroderma; Vasodilators

Indexed keywords

FUROSEMIDE; GLYCERYL TRINITRATE; LOSARTAN; MORPHINE; NIFEDIPINE; NITRIC OXIDE; OMEPRAZOLE; OXYGEN; PROSTACYCLIN; SPIRONOLACTONE; WARFARIN;

ADULT; AGED; ARTICLE; CALCINOSIS; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ESOPHAGUS INJURY; FEMALE; HUMAN; HYPOTENSION; LUNG EDEMA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SYNDROME CREST; TELANGIECTASIA;

EID: 0036167535     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.2.656     Document Type: Article

References (14)

1. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis
2. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)
3. Systemic sclerosis-associated pulmonary hypertension: Short- and long-term effects of epoprostenol (prostacyclin)
4. Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: Results of a pilot study
5. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial
6. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension
7. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure
8. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma
9. Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension
10. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): Results of a randomized trial
11. Pulmonary edema complicating prostacyclin therapy in pulmonary hypertension associated with scleroderma: A case of pulmonary capillary hemangiomatosis
12. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis
13. Left ventricular chamber function during inhaled nitric oxide in patients with dilated cardiomyopathy
14. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease